Population-based study of a free rubella-specific antibody testing and immunization campaign in Chiba city in response to the 2018–2019 nationwide rubella outbreak in Japan
Author:
Affiliation:
1. Department of Infectious Diseases, Medical Mycology Research Center, Chiba University, Chiba, Japan
2. Infectious Disease Prevention Division, Chiba City Health Center, Chiba, Japan
3. Chiba City Medical Association, Chiba, Japan
Funder
Chiba city in 2019
joint research funding shared with the Medical Mycology Research Center, Chiba University in 2020
Publisher
Informa UK Limited
Subject
Pharmacology,Immunology,Immunology and Allergy
Link
https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1847584
Reference22 articles.
1. World Health Organization. Global Vaccine Action Plan 2011–2020. [accessed 2020 October 23]. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/
2. Pan American Health Organization/World Health Organization (PAHO/WHO). Elimination of rubella and congenital rubella syndrome in the Americas. Fact sheet 2015. [accessed 2020 October 23]. https://www.paho.org/hq/dmdocuments/2015/rubella-elimination-factsheet-en.pdf
3. Towards rubella elimination in Japan
4. Epidemiological Characteristics of Rubella and Congenital Rubella Syndrome in the 2012–2013 Epidemics in Tokyo, Japan
5. Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan. Infectious diseases weekly report, report of congenital rubella syndrome. 2020 Jan 23 (Japanese). [accessed 2020 October 23]. https://www.niid.go.jp/niid/ja/rubella-m-111/700-idsc/8588-rubella-crs.html
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Gender differences in responses to an altruistic message regarding rubella vaccination;Frontiers in Public Health;2024-08-09
2. Developing computationally efficient optimal control strategies to eradicate Rubella disease;Physica Scripta;2024-02-01
3. Epidemiological characteristic of rubella by age group during 12 years after the national introduction of rubella vaccine in Hangzhou, China;Human Vaccines & Immunotherapeutics;2022-03-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3